High-Dose Intravenous Immunoglobulin Is Effective Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled Trial: Comments. [electronic resource]
- Pain medicine (Malden, Mass.) 10 2020
- 2603-2604 p. digital